Dr. Andrew Beardsley, MD
Claim this profileMessino Cancer Centers
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
3 reported clinical trials
6 drugs studied
Affiliated Hospitals
Clinical Trials Andrew Beardsley, MD is currently running
ONC-392 vs Chemotherapy
for Lung Cancer
This trial is testing gotistobart, a new drug that helps the immune system fight advanced lung cancer in patients who haven't responded to other treatments. It works by blocking a protein that allows cancer cells to hide from the immune system.
Recruiting2 awards Phase 310 criteria
Asciminib vs Nilotinib
for Chronic Myeloid Leukemia
The study is designed to compare the tolerability of asciminib versus nilotinib for the treatment of newly diagnosed, previously untreated patients with Positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP).
Recruiting3 awards Phase 3
More about Andrew Beardsley, MD
Clinical Trial Related1 year of experience running clinical trials · Led 3 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Andrew Beardsley, MD has experience with
- ONC-392
- Docetaxel
- Nilotinib
- Asciminib
- Tinengotinib
- Physician's Choice
Breakdown of trials Andrew Beardsley, MD has run
Lung Cancer
Non-Small Cell Lung Cancer
Philadelphia Chromosome
Myeloid Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Andrew Beardsley, MD specialize in?
Andrew Beardsley, MD focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Andrew Beardsley, MD currently recruiting for clinical trials?
Yes, Andrew Beardsley, MD is currently recruiting for 3 clinical trials in Asheville North Carolina. If you're interested in participating, you should apply.
Are there any treatments that Andrew Beardsley, MD has studied deeply?
Yes, Andrew Beardsley, MD has studied treatments such as ONC-392, Docetaxel, Nilotinib.
What is the best way to schedule an appointment with Andrew Beardsley, MD?
Apply for one of the trials that Andrew Beardsley, MD is conducting.
What is the office address of Andrew Beardsley, MD?
The office of Andrew Beardsley, MD is located at: Messino Cancer Centers, Asheville, North Carolina 28806 United States. This is the address for their practice at the Messino Cancer Centers.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.